The development, technology transfer, and current Good Manufacturing Practices implementation of a synthetic route designed for continuous processing is discussed in the context of an active clinical candidate.
Kevin Cole (Eli Lilly)
Kevin Cole (Eli Lilly)
Building: | Chemistry Dow Lab |
---|---|
Event Type: | Other |
Tags: | Chemistry, Science |
Source: | Happening @ Michigan from Department of Chemistry |